Here, we demonstrate, for the first time, that intracellular IL-1α in breast cancer cells can alter the TME to ensure their survival via expression of pro-inflammatory molecules and recruitment of myeloid immunosuppressive cells. The gene discussed is IL1A; the disease is breast cancer.